Biomed Pharma Reviews

Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions

Concordance is the wrong metric: Plasma against tissue genotyping in advanced lung cancer, and what a negative liquid biopsy actually rules out

A pooled sensitivity that describes no organ system: Prenatal ultrasound detection of fetal structural anomalies and the limits of averaging across anatomy

How much of the probiotic effect on necrotising enterocolitis survives restriction to low-risk-of-bias trials? A second-order meta-analysis in very preterm infants

A category, not an intervention: Remote patient monitoring in heart failure and the underpowered interaction tests used to justify pooling across it